Detailed price information for Gold X2 Mining Inc (GSHRF) from The Globe and Mail including charting and trades.

RIT's physician assistant program is a five-year, dual degree program where you'll earn both your bachelor's and your master's degrees. Based on the 2016 Statistical Profile of Certified Physician ...

With a physician assistant graduate degree, you’ll be equipped to offer holistic patient care with compassion, integrity, and purpose. At Bethel, you’ll experience a world-class physician assistant ...

“I am extremely grateful to have had such as empowering mentor such as Dr. Chao during my time in the SMART Program. She allowed me freedom in my research based on my interests and adequately ...

The ACS Approval Program promotes excellence in chemistry education for undergraduate students through approval of baccalaureate chemistry programs. ACS-approved programs offer a broad-based and ...

A loyalty program is a marketing strategy used by businesses to encourage repeat customers by offering incentives such as discounts and rewards. Loyalty programs are offered by retailers and other ...

On April 4, 1968 the ACS Council passed a resolution “to take the appropriate steps to ease the problems of underprivileged segments of the nation’s population, particularly in relation to lack of ...

As the California cannabis industry expands, you’ll likely find yourself searching for the best dispensary on the Peninsula. We created this list of the best recreational dispensaries nearby based on ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Defying national trends, Midtown Houston is growing. Named ...

The Yellow Ribbon Program is a provision of the Post-9/11 GI Bill that can help students attend expensive private schools at little or no cost to themselves. Normally, Post-9/11 GI Bill payments at ...

Lundbeck seems to have brought its migraine prevention drug bocunebart back on track, after dropping development of one formulation of the anti-PACAP antibody last year. Results from the phase 2b ...